MedTrace Logo

Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

NCT06924021 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-03-27

No results posted yet for this study

Summary

1000 participants from up to 25 international locations who are at least 50 years old with either healthy eyes or a diagnosis of Age-Related Macular Degeneration (AMD) will be consented to provide images of their eyes for a new dataset. This dataset is an important step in developing an Artificial Intelligence (AI) based screening tool for AMD.

Conditions

  • Age-Related Macular Degeneration

Interventions

OTHER

Retinal Imaging

Eligible participants will undergo one retinal imaging session of both eyes for the following: * Single field stereo color fundus photography (cFP) - pre and post dilation * Macular spectral domain-optical coherence tomography (SD-OCT)

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Amitha Domalpally, MD, PhD · UW School of Medicine and Public Health

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-12
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • United States
  • Argentina
  • Australia
  • France
  • Germany
  • India
  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06924021 on ClinicalTrials.gov